Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Lopez-Campos

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|November 15, 2018
Nanoparticles applied to cancer immunoregulationFernando Lopez-Campos, Danielle Candini, Eliseo Carrasco, et al.
Journal of Clinical Medicine|June 12, 2026
Long-Term Results of a Comparison Between 15 × 2.633 Gy and 20 × 2.0 Gy for Malignant Spinal Cord Compression in Patients with Longer Expected Survival TimesDirk Rades, Christian Staackmann, Darejan Lomidze, et al.
American Journal of Translational Research|June 17, 2024
Liquid biopsy to personalize treatment for metastatic prostate cancerMarta Lopez-Valcarcel, Fernando Lopez-Campos, Juan Zafra, et al.
Cancers|April 26, 2025
Impact of PSMA-PET/CT on Radiotherapy Decisions: Is There a Clinical Benefit?Elías Gomis-Sellés, Antonio Maldonado, Miren Gaztañaga, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 10, 2025
Ultrahypofractionated radiotherapy in one or two sessions for localized prostate cancer: a review of the evidence and future perspectivesMiguel Angel Berenguer-Frances, Abrahams Ocanto, Thomas Zilli, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Higher Dose Irradiation for Malignant Spinal Cord Compression: Long-Term Results of the RAMSES-01 TrialDirk Rades, Darejan Lomidze, Natalia Jankarashvili, et al.
Cancers|October 26, 2024
Radiotherapy with 15 × 2.633 Gy vs. 20 × 2.0 Gy in Patients with Malignant Spinal Cord Compression and Favorable Survival Prognoses: A Secondary Analysis of the RAMSES-01 TrialDirk Rades, Darejan Lomidze, Natalia Jankarashvili, et al.
Future Oncology (London, England)|March 3, 2025
Beyond the status quo: when disease volume and metastatic timing are not enough to personalize treatment in mHSPCÁngel Borque-Fernando, Teresa Alonso-Gordoa, María José Juan-Fita, et al.
Cancers|March 28, 2024
Radiotherapy for Metastatic Epidural Spinal Cord Compression with Increased Doses: Final Results of the RAMSES-01 TrialDirk Rades, Darejan Lomidze, Natalia Jankarashvili, et al.
International Journal of Molecular Sciences|August 28, 2025
Biomarkers in Localized Prostate Cancer: From Diagnosis to TreatmentMarta Lopez-Valcarcel, Fernando Lopez-Campos, Juan Zafra-Martín, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|November 15, 2018
Nanoparticles applied to cancer immunoregulationFernando Lopez-Campos, Danielle Candini, Eliseo Carrasco, et al.
Journal of Clinical Medicine|June 12, 2026
Long-Term Results of a Comparison Between 15 × 2.633 Gy and 20 × 2.0 Gy for Malignant Spinal Cord Compression in Patients with Longer Expected Survival TimesDirk Rades, Christian Staackmann, Darejan Lomidze, et al.
American Journal of Translational Research|June 17, 2024
Liquid biopsy to personalize treatment for metastatic prostate cancerMarta Lopez-Valcarcel, Fernando Lopez-Campos, Juan Zafra, et al.
Cancers|April 26, 2025
Impact of PSMA-PET/CT on Radiotherapy Decisions: Is There a Clinical Benefit?Elías Gomis-Sellés, Antonio Maldonado, Miren Gaztañaga, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 10, 2025
Ultrahypofractionated radiotherapy in one or two sessions for localized prostate cancer: a review of the evidence and future perspectivesMiguel Angel Berenguer-Frances, Abrahams Ocanto, Thomas Zilli, et al.
Current Oncology (Toronto, Ont.)|March 27, 2026
Higher Dose Irradiation for Malignant Spinal Cord Compression: Long-Term Results of the RAMSES-01 TrialDirk Rades, Darejan Lomidze, Natalia Jankarashvili, et al.
Cancers|October 26, 2024
Radiotherapy with 15 × 2.633 Gy vs. 20 × 2.0 Gy in Patients with Malignant Spinal Cord Compression and Favorable Survival Prognoses: A Secondary Analysis of the RAMSES-01 TrialDirk Rades, Darejan Lomidze, Natalia Jankarashvili, et al.
Future Oncology (London, England)|March 3, 2025
Beyond the status quo: when disease volume and metastatic timing are not enough to personalize treatment in mHSPCÁngel Borque-Fernando, Teresa Alonso-Gordoa, María José Juan-Fita, et al.
Cancers|March 28, 2024
Radiotherapy for Metastatic Epidural Spinal Cord Compression with Increased Doses: Final Results of the RAMSES-01 TrialDirk Rades, Darejan Lomidze, Natalia Jankarashvili, et al.
International Journal of Molecular Sciences|August 28, 2025
Biomarkers in Localized Prostate Cancer: From Diagnosis to TreatmentMarta Lopez-Valcarcel, Fernando Lopez-Campos, Juan Zafra-Martín, et al.
Pageof 2